Antares Pharma Inc (NASDAQ:ATRS)

2.72
Delayed Data
As of Apr 24
 -0.04 / -1.45%
Today’s Change
1.82
Today|||52-Week Range
3.20
+5.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$363.6M

Company Description

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing self-administered parenteral therapeutic products. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Contact Information

Antares Pharma, Inc.
100 Princeton South
Ewing New Jersey 08628
P:(609) 359-3020
Investor Relations:
(609) 359-3016

Employees

Shareholders

Mutual fund holders8.67%
Other institutional23.23%
Individual stakeholders11.75%

Top Executives

Eamonn P. HobbsPresident, Chief Executive Officer & Director
Robert F. AppleChief Operating Officer & Executive Vice President
James E. FickenscherChief Financial Officer & Senior Vice President
Peter L. SadowskiChief Technology Officer
Patrick MadsenVice President & GM-Parenteral Products Division

To view my watchlist

Not a member yet?

Sign up now for a free account